Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Deveaugh-Geiss

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Psychopharmacology Bulletin|January 1, 1989
Rebound withdrawal reactions due to clomipramineB I Diamond, R L Borison, R Katz, et al.
Psychopharmacology Bulletin|January 1, 1990
Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramineJ DeVeaugh-Geiss, R Katz, P Landau, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Oxiracetam in the treatment of multi-infarct dementiaB Baumel, L Eisner, M Karukin, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 14, 2001
Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessationJ A Johnston, J Fiedler-Kelly, E D Glover, et al.
Neurology|November 1, 1995
Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of educationP M Doraiswamy, A Krishen, F Stallone, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 1, 1992
Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trialJ DeVeaugh-Geiss, G Moroz, J Biederman, et al.
Neurology|April 1, 1996
NSAIDs and cognition in Alzheimer's diseaseP M Doraiswamy, A Krishen, F Stallone, et al.
Psychopharmacology|February 9, 2000
The effect of bupropion on nicotine craving and withdrawalS Shiffman, J A Johnston, M Khayrallah, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Psychopharmacology Bulletin|January 1, 1989
Rebound withdrawal reactions due to clomipramineB I Diamond, R L Borison, R Katz, et al.
Psychopharmacology Bulletin|January 1, 1990
Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramineJ DeVeaugh-Geiss, R Katz, P Landau, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Oxiracetam in the treatment of multi-infarct dementiaB Baumel, L Eisner, M Karukin, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 14, 2001
Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessationJ A Johnston, J Fiedler-Kelly, E D Glover, et al.
Neurology|November 1, 1995
Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of educationP M Doraiswamy, A Krishen, F Stallone, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 1, 1992
Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trialJ DeVeaugh-Geiss, G Moroz, J Biederman, et al.
Neurology|April 1, 1996
NSAIDs and cognition in Alzheimer's diseaseP M Doraiswamy, A Krishen, F Stallone, et al.
Psychopharmacology|February 9, 2000
The effect of bupropion on nicotine craving and withdrawalS Shiffman, J A Johnston, M Khayrallah, et al.
Pageof 3